Bel Fuse Inc /Nj
—- Market cap
- —
- Debt
- —
- Cash
- −$57.80M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: BELFA stock price vs APH: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at APH's multiple
Needs Annual EPS, APH P/E.
Implied fair value · at BELFA's multiple
Needs BELFA P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
BEL FUSE INC /NJ · implied price per share
A valid share-count denominator is required for the selected valuation policy.
AMPHENOL CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TE Connectivity plc
BELFA vs TEL
APPLIED MATERIALS INC /DE
BELFA vs AMAT
LITTELFUSE INC /DE
BELFA vs LFUS
ALASKA AIR GROUP, INC.
BELFA vs ALK
VISHAY INTERTECHNOLOGY INC
BELFA vs VSH
CORNING INC /NY
BELFA vs GLW
CommScope Holding Company, Inc.
BELFA vs COMM
HUBBELL INC
BELFA vs HUBB
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe BELFA's strong quality score and profitability can persist without a rerating to APH-like multiples, then favor BELFA as a value-oriented holding because its 8.3x P/E and 0.8x P/S leave room for upside versus both historical and DCF ranges; if you require APH-level growth and operating leverage, then APH comparison does not justify paying up to APH-style multiples.
BELFA trades at a steep discount to APH on both earnings and sales multiples, with P/E at 8.3x versus 51.6x and P/S at 0.8x versus 9.2x. The current price of $235.51 sits within the historical band but far below APH-implied range, suggesting the market is valuing BELFA more like a small-cap industrial than a high-growth franchise.
Supporting Metrics